HRD Detection for Ovarian Cancer Patients in China - BGI Perspectives
- First prospective cohort study in China shows potential for more effective ovarian cancer treatmentβ¦
BGIChina
Comparing US-China Colorectal Cancer Screening l BGI Perspectives
In recent years, cancer has become one of the major public health issues seriously threatening the Chinese population. According to the latest global cancer-related data for 2020 released by the International Agency for Research on Cancer (IARC) of the World Health Organization, 19.29 million new cancer cases and 9.96 million cancer-related deaths will occur.The number of new cancer cases far exceeds that of other countries in the world. According to the latest data released by the National Cancer Center in 2022, China spends more than $220 billion on cancer-related medical treatment each year, and the overall 5-year survival rate of cancer in China is significantly worse than that of developed countries, making the prevention and control situation very serious.Read more: https://www.bgi.com/global/news/us-and-chinese-colorectal-cancer-screening-programs-bgi-perspectivesAdditional Readings:https://www.nature.com/articles/d42473-022-00039-8https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097335/https://www.igb.illinois.edu/article/first-bgi-igb-workshop-takes-place-shenzen-chinaβ¦